TP53 and non-small cell lung carcinoma: In the present report, we have investigated the radiosensitizing properties of the Chk1 inhibitor, MK-8776, on human non-small lung cancer (NSCLC) cells and cells derived from head and neck squamous cell carcinomas (HNSCC) and test the p53 dependency of the radiosensitization.